Marex Group plc Ordinary Shares (MRX)
Official siteFINANCIAL SERVICES • CAPITAL MARKETS • NASDAQ
Market Cap: $5.12B
Last updated: Nov 17, 2026 at 11:06 AM ET
Marex Group plc Ordinary Shares (MRX) Financials: Revenue, Profit and Cash Flow
Marex Group plc Ordinary Shares reported revenue of $3.63B for the fiscal year ended Dec 31, 2025, up 25.4% from the year before. That year, net income was $308.20M with a net margin of 8.5%, operating cash flow was $667.50M and free cash flow was $654.40M. The quarter ended Sep 30, 2026 had revenue of $743.20M and net income of $130.30M.
Revenue and Margins
The operating margin was 32.0% in the fiscal year ended Dec 2025, the highest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from $328.31M, a compound annual rate of 30.6%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $3.63B | +25.4% | 74.7% | 32.0% | 8.5% |
| Dec 2024 | $2.89B | +23.1% | 44.5% | 28.9% | 7.5% |
| Dec 2023 | $2.35B | +100.1% | 72.0% | 29.1% | 5.4% |
| Dec 2022 | $1.18B | +38.0% | 73.4% | 23.0% | 7.8% |
| Dec 2021 | $851.70M | +12.4% | 96.9% | 8.1% | 6.6% |
| Dec 2020 | $757.53M | +37.9% | 100.0% | 7.5% | 5.8% |
| Dec 2019 | $549.19M | +42.8% | 100.0% | 2.2% | 6.6% |
| Dec 2018 | $384.47M | +20.9% | 100.0% | 11.8% | 2.6% |
| Dec 2017 | $317.90M | -3.2% | 100.0% | 7.9% | 5.5% |
| Dec 2016 | $328.31M | N/A | 100.0% | 8.0% | 6.2% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 41.4% from the year before. In the quarter ended Sep 2026, net income rose 78.0% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.63B | $2.89B | $2.35B | $1.18B | $851.70M | $757.53M | $549.19M | $384.47M | $317.90M | $328.31M |
| Cost of revenue | $917.70M | $1.61B | $659.40M | $313.00M | $609.50M | N/A | N/A | N/A | N/A | N/A |
| Gross profit | $2.71B | $1.29B | $1.69B | $862.30M | $825.30M | $757.53M | $549.19M | $384.47M | $317.90M | $328.31M |
| Research and development | $0 | $0 | $0 | $0 | $0 | $763.00K | $639.00K | $60.00K | $135.00K | $389.00K |
| Operating income | $1.16B | $836.30M | $683.50M | $270.50M | $68.60M | $56.58M | $12.23M | $45.24M | $25.24M | $26.33M |
| Net income | $308.20M | $218.00M | $128.00M | $91.60M | $56.50M | $43.82M | $36.39M | $10.15M | $17.50M | $20.49M |
| EBITDA | $1.21B | $865.80M | $705.40M | $284.30M | $106.60M | N/A | N/A | N/A | N/A | N/A |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $743.20M | $1.18B | $1.33B | $3.13B | $484.60M | $500.10M | $865.70M | $2.15B | $391.20M | $740.00M | $675.10M | $720.70M |
| Gross profit | $314.00M | $552.90M | $487.90M | $2.52B | $192.60M | $194.20M | $321.00M | $996.10M | $391.20M | $291.10M | $263.50M | $720.70M |
| Operating income | $172.30M | $416.90M | $362.50M | $1.06B | $94.60M | $100.80M | $239.30M | $437.10M | $79.00M | $391.20M | $186.40M | -$116.70M |
| Net income | $130.30M | $267.70M | $112.40M | $231.50M | $73.20M | $76.70M | $72.50M | $115.10M | $58.40M | $102.90M | $43.60M | $50.50M |
Balance Sheet
As of Dec 2025, total debt of $10.15B exceeded cash and equivalents by $3.77B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $34.68B | $24.31B | $17.61B | $15.74B | $5.26B | $3.77B | $2.58B | $1.39B | $1.08B | $1.14B |
| Current assets | $24.53B | $23.83B | $16.94B | $15.35B | $4.12B | $291.55M | $217.50M | N/A | N/A | N/A |
| Cash and equivalents | $6.38B | $2.56B | $1.48B | $910.10M | $712.00M | $291.55M | $217.50M | $160.73M | $89.22M | $188.18M |
| Total liabilities | $33.41B | $23.34B | $16.84B | $15.07B | $4.79B | $3.32B | $2.16B | $1.01B | $712.27M | $761.50M |
| Short-term debt | $7.82B | $4.59B | $4.44B | $5.22B | $1.14B | N/A | N/A | N/A | N/A | N/A |
| Long-term debt | $2.33B | $1.48B | $907.90M | $135.80M | $136.60M | N/A | N/A | N/A | N/A | N/A |
| Shareholder equity | $1.26B | $976.90M | $775.90M | $677.70M | $477.70M | $443.79M | $417.75M | $381.93M | $372.38M | $373.83M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $45.40B | $42.13B | $36.53B | $34.68B | $32.94B | $31.19B | $24.35B | $24.31B | $19.51B | $17.19B | N/A | $17.61B |
| Total liabilities | $43.44B | $40.26B | $35.18B | $33.41B | $31.76B | $30.08B | $23.31B | $23.34B | $18.55B | $16.31B | N/A | $16.84B |
| Cash and equivalents | $3.21B | $3.85B | $3.07B | $6.38B | $3.11B | $6.91B | $2.61B | $2.56B | $5.83B | $1.91B | N/A | $1.48B |
| Shareholder equity | $1.97B | $1.87B | $1.35B | $1.26B | $1.18B | $1.11B | $1.05B | $976.90M | $959.80M | $882.30M | $775.90M | $775.90M |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 98.0% of operating cash flow. Dividends came to 8.5% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $667.50M | $1.16B | $735.00M | $225.60M | $470.80M | -$45.78M | -$23.14M | $130.29M | -$95.53M | $30.10M |
| Capital expenditures | $13.10M | $19.90M | $12.10M | $9.40M | $7.30M | $3.36M | $2.76M | $1.03M | $1.69M | $1.26M |
| Free cash flow | $654.40M | $1.14B | $722.90M | $216.20M | $463.50M | -$49.14M | -$25.90M | $129.27M | -$97.22M | $28.84M |
| Dividends paid | $55.50M | $77.10M | $58.30M | $6.60M | $20.00M | $18.20M | N/A | N/A | $20.00M | $20.00M |
| Investing cash flow | -$264.30M | -$35.30M | -$97.60M | -$46.30M | -$19.80M | -$31.05M | -$106.15M | -$2.59M | -$2.13M | -$1.41M |
| Financing cash flow | -$123.90M | -$37.20M | -$72.80M | $26.50M | -$27.20M | $150.88M | $186.07M | -$56.20M | -$1.30M | $1.23M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | N/A | $701.40M | N/A | -$260.20M | N/A | $927.70M | N/A | $711.00M | N/A | $452.50M | N/A | $367.50M |
| Capital expenditures | $0 | $9.40M | $0 | $4.30M | $0 | $8.80M | $0 | $6.40M | $0 | $9.20M | $0 | $6.05M |
| Free cash flow | N/A | $692.00M | N/A | -$264.50M | N/A | $918.90M | N/A | $704.60M | N/A | $443.30M | N/A | $361.45M |
Frequently Asked Questions About MRX
What is Marex Group plc Ordinary Shares' annual revenue?
Marex Group plc Ordinary Shares reported revenue of $3.63B for the fiscal year ended Dec 31, 2025.
How fast is Marex Group plc Ordinary Shares' revenue growing?
Revenue was up 25.4% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 45.6%.
Is Marex Group plc Ordinary Shares profitable?
Yes. Marex Group plc Ordinary Shares reported net income of $308.20M for the fiscal year ended Dec 31, 2025, with a net margin of 8.5%.
How much free cash flow does MRX generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $667.50M minus capital expenditures of $13.10M produced free cash flow of $654.40M.
How much debt does Marex Group plc Ordinary Shares have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $2.33B, short-term debt of $7.82B and cash and equivalents of $6.38B.
MRX pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors